In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

HFA Cardio Talk

Available on your favourite apps

April 2022

Tips and tricks in interpretation of clinical trials
Petar Seferovic.jpg

Prof. Petar M. Seferović
University of Belgrade Faculty of Medicine – Belgrade, Serbia



Dr. Ivan Milinković
University of Belgrade Faculty of Medicine – Belgrade, Serbia


The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment

March 2022

Implementing the use of HF treatments in clinical practice

Prof. Gianluigi Savaresse
Karolinska Institute – Stockholm, Sweden


Otilia Tica.jpg

Dr. Otilia Țica
Emergency County Hospital of Oradea - Oradea, Romania 


This podcast will discuss the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HOT committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.


February 2022

The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

Giuseppe Rosano
St George's Hospital Medical School – London, UK


A. Cannata.jpg

Dr. Antonio Cannata
King's College London - London, UK


This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.


January 2022

Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines

Prof. Ewa A. Jankowska
Wroclaw Medical University - Wroclaw, Poland



Mateusz Sokolski
Wroclaw Medical University - Wroclaw, Poland


The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HOT Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.

The content of this podcast reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.